Viewpoint: ‘Mass tort litigation is a big business’ — How litigation mills are targeting agricultural chemicals

Credit: Levin Law
Credit: Levin Law

If you were watching television in almost any U.S. market in March and April, you probably saw advertisements soliciting would-be plaintiffs who were exposed to the crop-protection tool paraquat and later developed Parkinson’s disease. Nearly 15,000 commercials ran in April to the tune of $1.9 million. The lawsuits aimed at paraquat aren’t new — they started back in 2017 — but the media blitz was the highest ever in March and April of 2022. Though the 2021 campaign was nothing to sneeze at.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

Unfortunately, mass tort litigation is a big business. As any lawyer, myself included, will tell you that litigation is expensive, even when you have a good case. These large-scale cases require more capital, sometimes attracting third-party investors, like hedge funds. In other words, there are literally financiers, with no connection to the case, who profit when plaintiffs recover big judgments.

These mass tort firms now have a recipe for success: Invent questionable scientific evidence, find a sympathetic plaintiff, sue the manufacturer, and payday. This isn’t about justice or paying for someone’s cancer treatments — this is about big money. For farmers, that’s a scary prospect. Roundup, paraquat, and other pesticides are important crop-protection tools. How many multi-million-dollar lawsuits can the manufacturers withstand before they decide it isn’t worth it?

This is an excerpt. Read the original post here

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Sep-23-2026-02_36_39-PM
Viewpoint: After firing the entire National Science Board, Trump reshapes funding initiatives. Here’s the good and the bad.
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Sep-10-2026-10_36_07-AM
Viewpoint: Even lousy scientific articles can shield authors when they hype dubious health claims and products
sorghum farmers in kenya FARMERS TREND
Here are all the ways CRISPR gene editing is transforming Africa’s staple crops—and there’s a lot more innovation to come
Screenshot-2026-10-01-at-11.21.27-AM
Vaccine hesitancy, like malaria, surges globally, topping 35% in some countries
ChatGPT-Image-Sep-30-2026-01_25_34-PM
Blood tests for Alzheimer’s? The latest grifter, social media scam.
ChatGPT-Image-Sep-30-2026-01_38_36-PM
Viewpoint: Died “with measles” vs. died “from measles”: RFK, Jr.’s dangerously subversive word games
ChatGPT-Image-Sep-21-2026-03_15_09-PM
Viewpoint: Chipotle-inspired lesson: 10,000 sick customers suggest that processed foods can be safer than fresh ones
ChatGPT-Image-Sep-30-2026-01_11_07-PM
How U.S. teamed with Russia to block global human AI weapons oversight
Screenshot-2026-09-28-at-1.16.38-PM
Defying public perceptions, U.S. cancer deaths plunged 35% since 1991
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.